Kenvue Inc.
Veridion Score
Composite trend over time
Why is KVUE moving today?
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold, and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced in November 2025 that it signed a deal to be fully acquired by Kimberly-Clark, with the deal expected to close during the second half of 2026.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Warehouse intelligence for KVUE.
KVUE insider activity
Kenvue Inc.
No multi-insider buying cluster in the last 90 days
Mixed: Not disclosed across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
The current Form 4 feed did not return value-bearing open-market rows for KVUE.
KVUE contract awards, year to date.
Public federal awards linked to this ticker.
KVUE lobbying filings, year to date.
Registered lobbying filings matched to Kenvue Inc..